Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06084949
Other study ID # HSEARS20230703001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 5, 2023
Est. completion date August 31, 2026

Study information

Verified date September 2023
Source The Hong Kong Polytechnic University
Contact Tracy Tang
Phone +852 3400 8541
Email tracy-wh.tang@polyu.edu.hk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this randomized controlled trial is to evaluate the effect of Nordic walking and inspiratory muscle training (IMT) on cardiopulmonary function in patients with knee osteoarthritis (OA). Mild-to-moderate knee OA patients are randomly allocated into Experimental group (Nordic walking plus routine management) or Control group (Routine management). While End-stage knee OA patients are randomly allocated into Experimental group (IMT plus pre-operative rehabilitation exercise) or Control group (Pre-operative rehabilitation exercise). Participants are invited to undergo two assessments, including baseline assessment, post-intervention assessment. Researchers will compare two groups to see if the cardiopulmonary function can be improved after intervention.


Description:

This study recruits patients with different stages and assigns them into different interventions and comparing the effect with those not receiving intervention. It will provide the evidence in terms of the exercise that can promote cardiopulmonary function and at the same time reduce pain and disability for patients with different stages of knee osteoarthritis.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date August 31, 2026
Est. primary completion date August 31, 2026
Accepts healthy volunteers No
Gender All
Age group 55 Years and older
Eligibility Inclusion Criteria: - pain on the most days in one or both knees in the past month; - difficulty with at least one of daily living activities measured by the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale; - radiographic evidence of knee OA in the tibial-femoral compartment (Kellgren and Lawrence grade, K/L =1, K/L 1-3 regarded as mild-to-moderate knee OA, others waiting for knee arthroplasty regarded as end-stage knee OA); - with normal or corrected visual and auditory function and walking unaided; - primary knee OA for more than 6 months, be stable on medication for at least 3 weeks. Exclusion Criteria: - knee surgery priorly; - have steroid injection in previous three weeks; - have inflammatory arthritis (e.g., rheumatoid); or unstable angina, or myocardial infarction, or cardiac surgery; or stroke; or treatment with steroids, hormones, or cancer chemotherapy; or pulmonary diseases (force vital capacity<80% of predicted and/or forced expiratory volume at first second<70% of predicted); or a history of exercise-induced asthma; - unable to understand the procedure and potential risks of the study; - medically unstable that indicate unsafe to participate in exercise test

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Nordic walking or inspiratory muscle training
Nordic walking is a form of low-impact aerobic exercise that incorporates the use of walking poles. And inspiratory muscle training is a type of exercise that provides resistance during the inhalation phase.

Locations

Country Name City State
Hong Kong The Hong Kong Polytechnic University Kowloon City Kowloon

Sponsors (2)

Lead Sponsor Collaborator
The Hong Kong Polytechnic University Kwong Wah Hospital

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary The six-minute walk test Cardiopulmonary function Baseline, up to 8 weeks
Primary 30-sec chair stand test Cardiopulmonary function Baseline, up to 8 weeks
Primary Grip strength Cardiopulmonary function Baseline, up to 8 weeks
Primary Timed up-and-go test Cardiopulmonary function Baseline, up to 8 weeks
Primary Quadriceps strength Cardiopulmonary function Baseline, up to 8 weeks
Secondary Forced vital capacity Pulmonary function Baseline, up to 8 weeks
Secondary Forced expiratory volume at first second Pulmonary function Baseline, up to 8 weeks
Secondary Maximum voluntary ventilation Pulmonary function Baseline, up to 8 weeks
Secondary Inspiratory muscle strength Pulmonary function Baseline, up to 8 weeks
Secondary Inspiratory muscle endurance Pulmonary function Baseline, up to 8 weeks
Secondary Quadriceps muscle oxygenation Quadriceps muscle function Baseline, up to 8 weeks
Secondary Multidimensional Fatigue Inventory Total scores range from 20-100, , the higher scores indicating a higher level of fatigue. Baseline, up to 8 weeks
Secondary Medical Research Council scale Total scores range from 0-4, the higher scores indicating a higher level of dyspnea. Baseline, up to 8 weeks
Secondary Physical Activity Scales for the Elderly Total scores range from 0-793, the higher scores indicating a higher level of physical activity. Baseline, up to 8 weeks
Secondary Actigraph Physical activity level Baseline, up to 8 weeks
Secondary Pittsburgh Sleep Quality Index Total scores range from 0-21, '0' indicating no difficulty and '21' indicating severe difficulties in all areas. Baseline, up to 8 weeks
Secondary Western Ontario and McMaster Universities Osteoarthritis Index Knee-related symptoms and function, total scores range from 0-96, the higher scores indicating the worse symptom and function. Baseline, up to 8 weeks
Secondary 12-Item Short Form Health Survey Total scores range from 0-100, the higher scores indicating better physical and mental health functioning. Baseline, up to 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Completed NCT02905747 - The Effect of Medical Exercise Therapy on Pain, Function and Physical Activity in Patients With Knee Osteoarthritis N/A
Completed NCT03037489 - A Study to Evaluate Safety and Tolerability of MIV-711 in Osteoarthritis Patients Phase 2
Terminated NCT02615522 - Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration